Ingevity Corp buy BMO Capital Markets
Start price
05.09.25
/
50%
€51.00
Target price
05.09.26
€58.30
Performance (%)
-11.73%
Price
05.12.25
€44.40
Summary
This prediction is currently active. The price of Ingevity Corp has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.73%. This prediction currently runs until 05.09.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | -0.804% | -0.804% |
| iShares Core DAX® | 0.760% | -0.301% |
| iShares Nasdaq 100 | 0.732% | -1.001% |
| iShares Nikkei 225® | 1.025% | -3.621% |
| iShares S&P 500 | -0.036% | -0.194% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $62.00 to $68.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat